These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 35469617)

  • 41. [Severe allergic reaction due to a rectal enema].
    Raulin-Gaignard H; Berlengi N; Gatin A; Loeb O; Borsa-Dorion A; Monin P
    Arch Pediatr; 2013 Dec; 20(12):1329-32. PubMed ID: 24183833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anaphylaxis to drug excipients.
    Pfützner W
    Allergo J Int; 2022; 31(5):137-140. PubMed ID: 35669611
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interactions between active pharmaceutical ingredients and excipients affecting bioavailability: impact on bioequivalence.
    García-Arieta A
    Eur J Pharm Sci; 2014 Dec; 65():89-97. PubMed ID: 25236823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Xolair-induced recurrent anaphylaxis through sensitization to the excipient polysorbate.
    Perino E; Freymond N; Devouassoux G; Nicolas JF; Berard F
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):664-666. PubMed ID: 29481891
    [No Abstract]   [Full Text] [Related]  

  • 45. A comprehensive review on pharmaceutical excipients.
    Pockle RD; Masareddy RS; Patil AS; Patil PD
    Ther Deliv; 2023 Jul; 14(7):443-458. PubMed ID: 37464784
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaphylactic reaction to galactose-derived oligosaccharide residues from lactose used as a drug excipient.
    Andrade ALMB; Riccetto AGL; Vilela MMDS; de Oliveira DN; Catharino RR; Nolasco da Silva MT
    Pediatr Allergy Immunol; 2018 Mar; 29(2):207-210. PubMed ID: 29197126
    [No Abstract]   [Full Text] [Related]  

  • 47. Severe Polyethylene Glycol Allergy Considerations for Perioperative Management: A Case Report.
    Wong-On-Wing A; Ruth K; Hinerth K; Deng A; Woldekiros M; Ellenbogen RG; Crowder CM
    A A Pract; 2022 Oct; 16(10):e01619. PubMed ID: 36219725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Quantitative Investigation on Exposure to Potentially Harmful Excipients by Injection Drug Administration in Children Under 2 Years of Age and Analysis of Association with Adverse Events: A Single-Center, Retrospective Observational Study.
    Saito J; Nakamura H; Akabane M; Yamatani A
    Ther Innov Regul Sci; 2024 Mar; 58(2):316-335. PubMed ID: 38055156
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of pediatric patients with suspected polyethylene glycol and polysorbate allergy before mRNA SARS-CoV2 vaccination.
    Karaaslan BG; Burtecene N; Mustu U; Ocak S; Kasapcopur O; Kıykım A; Cokugras H
    Allergol Immunopathol (Madr); 2023; 51(3):174-180. PubMed ID: 37169575
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of hydroperoxides in common pharmaceutical excipients.
    Wasylaschuk WR; Harmon PA; Wagner G; Harman AB; Templeton AC; Xu H; Reed RA
    J Pharm Sci; 2007 Jan; 96(1):106-16. PubMed ID: 16917844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmaceutical Excipients and Drug Metabolism: A Mini-Review.
    Patel R; Barker J; ElShaer A
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Excipient-drug interactions in parenteral formulations.
    Akers MJ
    J Pharm Sci; 2002 Nov; 91(11):2283-300. PubMed ID: 12379914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of concerning excipients on animal safety: insights for veterinary pharmacotherapy and regulatory considerations.
    Thomazini VC; da Cunha GM; Guimarães NM; Saleme SD; de Melo RCG; de Paula GA; Carvalho SG; Chorilli M; Dos Santos Giuberti C; Villanova JCO
    Daru; 2024 Jun; 32(1):289-305. PubMed ID: 37903944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. "Inactive" ingredients in oral medications.
    Reker D; Blum SM; Steiger C; Anger KE; Sommer JM; Fanikos J; Traverso G
    Sci Transl Med; 2019 Mar; 11(483):. PubMed ID: 30867323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Place of excipients in systemic drug allergy.
    Barbaud A
    Immunol Allergy Clin North Am; 2014 Aug; 34(3):671-9, x. PubMed ID: 25017684
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inconsistent excipient listings in DailyMed: implications for drug safety.
    Kinsella L; Brook J; Briest M; Brook MJ
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Apr; ():. PubMed ID: 38563879
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmaceutical excipient development: the need for preclinical guidance.
    Baldrick P
    Regul Toxicol Pharmacol; 2000 Oct; 32(2):210-8. PubMed ID: 11067777
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The evolution and challenges for the international harmonization of the regulation of pharmaceutical excipients in Taiwan.
    Chang LC; Kang JJ; Gau CS
    Regul Toxicol Pharmacol; 2015 Dec; 73(3):947-52. PubMed ID: 26387930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas.
    Turner MA; Duncan JC; Shah U; Metsvaht T; Varendi H; Nellis G; Lutsar I; Yakkundi S; McElnay JC; Pandya H; Mulla H; Vaconsin P; Storme T; Rieutord A; Nunn AJ
    Adv Drug Deliv Rev; 2014 Jun; 73():89-101. PubMed ID: 24239480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Harmful excipients in medicines for neonates in Spain.
    Garcia-Palop B; Movilla Polanco E; Cañete Ramirez C; Cabañas Poy MJ
    Int J Clin Pharm; 2016 Apr; 38(2):238-42. PubMed ID: 26960405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.